Cullinan Therapeutics Q1 EPS $(0.75) Beats $(0.87) Estimate
Benzinga Newsdesk 6 months ago
EarningsEarnings BeatsNews
Cullinan Therapeutics (NASDAQ:CGEM) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.87) by 13.79 percent. This is a 1.35 percent decrease over losses of $(0.74) per share
Cullinan Therapeutics (NASDAQ:CGEM) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.87) by 13.79 percent. This is a 1.35 percent decrease over losses of $(0.74) per share from the same period last year.